METHOD FOR TREATMENT AND PREVENTION OF DISTURBANCES OF THE CENTRAL NERVOUS SYSTEM ASSOCIATED WITH AN ALTERATION OF GLUTAMATERGIC NEUROTRANSMISSION BY ADMINISTRATION OF 2-AMINOBENZENESULFONAMIDE DERIVATIVES

Title:

Document Type and Number:

WIPO Patent Application WO2002089734

Kind Code:

A3

Abstract:

2-aminobenzenesulfonamide derivatives are used for the treatment or prevention of the disturbances of the central nervous system associated with a positive or negative modulation of glutamatergic neurotransmission, such as disturbances of memory and learning, schizophrenia, sexual disturbances, ischemic attacks, ictus, etc. For example, a compound according to formula (I): is administered to treat or prevent diseases of the central nervous system having a positive or negative modulation of AMPA/Kainate receptors and a negative modulation of NMDA receptors.

More Like This:

JP5697893	Dosage form and drug administration method
JP2011507910	How to change the lifespan of eukaryotes
WO1999064055	MULTIVALENT AGONISTS, PARTIAL AGONISTS, INVERSE AGONISTS AND ANTAGONISTS OF THE 5HT4 RECEPTORS

Inventors:

CANNAZZA GIUSEPPE (IT)
PARENTI CARLO (IT)
LINDNER WOLFGANG (IT)
PUIA GIULIA (IT)
BARALDI MARIO (IT)
BRAGHIROLI DANIELA (IT)
TAIT ANNALISA (IT)

Application Number:

PCT/US2002/014262

Publication Date:

March 06, 2003

Filing Date:

May 07, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

RETT CORP (US)
CANNAZZA GIUSEPPE (IT)
PARENTI CARLO (IT)
LINDNER WOLFGANG (IT)
PUIA GIULIA (IT)
BARALDI MARIO (IT)
BRAGHIROLI DANIELA (IT)
TAIT ANNALISA (IT)

International Classes:

A61K31/136; A61K31/18; (IPC1-7): A61K31/04

Foreign References:

US6083947A	2000-07-04
US5536719A	1996-07-16

Other References: